Beech Tree Labs Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • 2ndary - Private

Beech Tree Labs General Information

Description

Developer of therapeutic agents designed to address a spectrum of unmet medical needs. The company's therapeutic agents have an extensive portfolio of patented formulations for products that treat such disorders as urinary incontinence, allergies, benign prostatic hypertrophy, anxiety, chronic obstructive pulmonary disease, and herpesvirus infections, enabling clients to discover early-stage development of these agents which can then be licensed to the appropriate company.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 1 Virginia Avenue
  • Suite 103
  • Providence, RI 02905
  • United States
+1 (401) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Beech Tree Labs Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Secondary Transaction - Private 01-Nov-2022 000.00 Completed Clinical Trials - Phase 2
5. Later Stage VC (Series C) 24-Sep-2015 00000 000.00 Completed Clinical Trials - Phase 2
4. Later Stage VC (Series B) 16-Nov-2010 00.000 000.00 000.00 Completed Clinical Trials - Phase 2
3. Grant 01-Nov-2010 00000 00.000 Completed Clinical Trials - Phase 2
2. Seed Round 15-Mar-2010 $1.46M $8.46M Completed Clinical Trials - Phase 2
1. Angel (individual) 02-Nov-2006 $7M $7M 0000 Completed Clinical Trials - Phase 2
To view Beech Tree Labs’s complete valuation and funding history, request access »

Beech Tree Labs Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 000,000 00.000000 00.00 00.00 00 00.00 0.000
Series A 0,000,000 00.000000 00.00 00 00 00 00 00.00
To view Beech Tree Labs’s complete cap table history, request access »

Beech Tree Labs Patents

Beech Tree Labs Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4126034-A1 Method of treating coronavirus infection by administration of ethyl mercury or thiol derivative thereof Inactive 27-Mar-2020 0000000000
US-20230398090-A1 Method of treating coronavirus infection by administration of ethyl mercury or thiol derivative thereof Pending 27-Mar-2020 0000000000
US-20180028602-A1 Method of inhibiting microglial cell migration and treating traumatic brain injury Active 08-Apr-2015 0000000000
US-10213480-B2 Method of inhibiting microglial cell migration and treating traumatic brain injury Active 08-Apr-2015 0000000000 00
AU-2016246713-B2 Methods of treating a traumatic brain injury Active 08-Apr-2015 A61K38/164 0
To view Beech Tree Labs’s complete patent history, request access »

Beech Tree Labs Executive Team (3)

Name Title Board Seat Contact Info
John McMichael Ph.D Founder, Chief Executive Officer, President, and Board Member
Thomas Hatch Director of Business Development
Kenneth Smith Director of Communications
To view Beech Tree Labs’s complete executive team members history, request access »

Beech Tree Labs Board Members (9)

Name Representing Role Since
Doug Hulse Self Board Member 000 0000
John Glasson ESQ Beech Tree Labs Board Member 000 0000
John McMichael Ph.D Beech Tree Labs Founder, Chief Executive Officer, President, and Board Member 000 0000
You’re viewing 3 of 9 board members. Get the full list »

Beech Tree Labs Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Beech Tree Labs FAQs

  • When was Beech Tree Labs founded?

    Beech Tree Labs was founded in 2004.

  • Who is the founder of Beech Tree Labs?

    John McMichael Ph.D is the founder of Beech Tree Labs.

  • Who is the CEO of Beech Tree Labs?

    John McMichael Ph.D is the CEO of Beech Tree Labs.

  • Where is Beech Tree Labs headquartered?

    Beech Tree Labs is headquartered in Providence, RI.

  • What is the size of Beech Tree Labs?

    Beech Tree Labs has 2 total employees.

  • What industry is Beech Tree Labs in?

    Beech Tree Labs’s primary industry is Drug Discovery.

  • Is Beech Tree Labs a private or public company?

    Beech Tree Labs is a Private company.

  • What is Beech Tree Labs’s current revenue?

    The current revenue for Beech Tree Labs is 000000.

  • How much funding has Beech Tree Labs raised over time?

    Beech Tree Labs has raised $15.2M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »